The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $36.06

Today's change+0.33 +0.92%
Updated July 31 4:03 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $36.06

Today's change+0.33 +0.92%
Updated July 31 4:03 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc Hits New 52-week High

Pfizer Inc closed up Friday by (U.S.)$0.33 or 0.92% to (U.S.)$36.06 and setting a new 52-week high. Over the last five days, shares have gained 5.25% and are currently 1.10% off of the 52-week high. Shares have outperformed the S&P 500 by 16.68% during the last year.

Key company metrics

  • Open(U.S.) $35.91
  • Previous close(U.S.) $35.73
  • High(U.S.) $36.46
  • Low(U.S.) $35.87
  • Bid / Ask-- / --
  • YTD % change+15.76%
  • Volume29,004,377
  • Average volume (10-day)24,804,653
  • Average volume (1-month)22,612,816
  • Average volume (3-month)22,563,098
  • 52-week range(U.S.) $27.51 to (U.S.) $36.46
  • Beta0.75
  • Trailing P/E25.57×
  • P/E 1 year forward17.54×
  • Forward PEG3.10×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield3.11%
  • Trailing EPS(U.S.) $1.41
Updated July 31 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.56%

Based on its net profit margin of 18.56%, Pfizer Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 29, 201506/29/2015Mar 29, 201503/29/2015Dec 31, 201412/31/2014Sep 28, 201409/28/2014
Revenue11,85310,86413,11812,361
Total other revenue--------
Total revenue11,85310,86413,11812,361
Gross profit9,6909,03510,43310,006
Total cost of revenue2,1631,8292,6852,355
Total operating expense8,1747,70111,2158,621
Selling / general / administrative3,3863,1043,9813,556
Research & development1,7341,8853,2091,802
Depreciation / amortization872940949972
Interest expense (income), net operating--------
Unusual expense (income)290170531265
Other operating expenses, total-271-227-140-329
Operating income3,6793,1631,9033,740
Interest income (expense), net non-operating-278-309-353-343
Gain (loss) on sale of assets191752153
Other--------
Income before tax3,5393,0821,8033,587
Income after tax2,6342,3761,2582,676
Income tax, total905706545911
Net income2,6262,3751,2292,667
Total adjustments to net income00-1-1
Net income before extra. items2,6252,3701,2512,670
Minority interest-9-6-7-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,6252,3701,2502,669
Inc. avail. to common incl. extra. items2,6262,3751,2282,666
Diluted net income2,6262,3751,2282,666
Dilution adjustment--0----
Diluted weighted average shares6,2436,2926,3736,403
Diluted EPS excluding extraordinary itemsvalue per share0.420.380.200.42
Dividends per sharevalue per share0.280.280.260.26
Diluted normalized EPSvalue per share0.450.370.280.45